TrulanceImmediate release (Synergy Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Trulance drug offered from Synergy Pharmaceuticals Inc.. This Guanylate Cyclase-C Agonist [EPC],Guanylate Cyclase Activators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Synergy Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | Plecanatide |
SUBSTANCE NAME: | PLECANATIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Guanylate Cyclase-C Agonist [EPC],Guanylate Cyclase Activators [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-02-21 |
END MARKETING DATE: | 0000-00-00 |
Trulance Immediate release HUMAN PRESCRIPTION DRUG Details:
Item Description | Trulance Immediate release from Synergy Pharmaceuticals Inc. |
LABELER NAME: | Synergy Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3(mg/1) |
START MARKETING DATE: | 2017-02-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70194-003_ca278606-3ce4-4745-9879-26992a45c910 |
PRODUCT NDC: | 70194-003 |
APPLICATION NUMBER: | NDA208745 |
Other PLECANATIDE Pharmaceutical Manufacturers / Labelers: